Trials / Recruiting
RecruitingNCT05937620
Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer
Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and Indocyanine Green (ICG) in Patients With Epithelial Ovarian Cancer in Early Stages: Pilot Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- Fundacion Clinic per a la Recerca Biomédica · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study to evaluate the diagnostic precision of ICG and 99mTc nanocolloid albumin in sentinel lymph node detection in early ovarian epithelial cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 99mTC nanocolloid albumin injection | All patients will receive an injection of both tracers in order to detect the sentinel lymph node |
| DIAGNOSTIC_TEST | ICG injection | All patients will receive an injection of both tracers in order to detect the sentinel lymph node |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2023-07-10
- Last updated
- 2026-02-09
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05937620. Inclusion in this directory is not an endorsement.